EcoDrugPlus

Cyclin Dependent Kinase 5

Ensembl ID : ENSCHAG00000010193
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSCHAG00000018905
Gene Symbol: CDK2
1 Cross references
203 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSCHAG00000017641
Gene Symbol: CDK4
1 Cross references
239 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSCHAG00000016088
Gene Symbol: CDK6
1 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSCHAG00000023401
Gene Symbol: CDK7
1 Cross references
219 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSCHAG00000007237
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSCHAG00000015042
Gene Symbol: CYSLTR1
1 Cross references
176 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSCHAG00000013522
Gene Symbol: CYSLTR1
1 Cross references
176 Possible Orthologues:

Cytidine Deaminase A

Ensembl ID : ENSCHAG00000000214
Gene Symbol: CDAA
1 Cross references
163 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSCHAG00000011329
Gene Symbol: CDAB
1 Cross references
197 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSCHAG00000011350
Gene Symbol: LOC105898129
3 Cross references
197 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSCHAG00000024185
Gene Symbol: LOC105891210
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).